Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $15.6150 (-7.38%) ($15.6150 - $15.6150) on Fri. Dec. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.69% (three month average) | RSI | 18 | Latest Price | $15.6150(-7.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -8.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -20% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(71%) ARKG(66%) IBB(64%) ARKK(62%) IWO(61%) | Factors Impacting TGTX price | TGTX will decline at least -2.845% in a week (0% probabilities). VIXM(-49%) VXX(-41%) UUP(-19%) UNG(-6%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.845% (StdDev 5.69%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-20.02(-228.21%) | Resistance Level | $25.47 | 5 Day Moving Average | $17.33(-9.9%) | 10 Day Moving Average | $20.64(-24.35%) | 20 Day Moving Average | $25.47(-38.69%) | To recent high | -56.1% | To recent low | 2.9% | Market Cap | $1.978b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |